Therefore, we can speculate that due to the absence of these HLA-related risk factors, ACPA initiation in IBD is not followed by a maturation of the ACPA response and spreading of epitopes, which can be measured in the context of RA development. This evidence concerns the gene PRTN3 and rheumatoid arthritis.